Home
>
US Stocks
>
Altimmune Inc
Altimmune Inc
ALT

Altimmune Inc (ALT)

$113.42%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$11.41
Today Low/High$10.98 / $11.68
52 Week Low/High$7.8 / $24.61
Market Cap$452.25M

Company Details

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Its diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).
OrganisationAltimmune Inc
HeadquatersGaithersburg, Maryland, US
Employees43
IndustryCommercial Services
CEOVipin Garg

Discover more

Frequently Asked Questions

What is Altimmune Inc (ALT) share price today?

Can Indians buy Altimmune Inc (ALT) shares?

How can I buy Altimmune Inc (ALT) shares from India?

Can Fractional shares of Altimmune Inc (ALT) be purchased?

What are the documents required to start investing in Altimmune Inc (ALT) stocks?

We are a SEBI registered investement advisor